Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Corvus Pharmaceuticals, Inc. (CRVS)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
15 May 2023
Grais Linda
Director
Corvus Pharmaceuticals, Inc.
(CRVS)
10,000
+100%
10,000
$2.45
$24,500.00
BUY
20 Dec 2022
Jones William Benton
See Remarks, Officer
Corvus Pharmaceuticals, Inc.
(CRVS)
133,773
+17%
20,000
$0.79
$15,800.00
BUY
13 Dec 2022
MILLER RICHARD A MD
President and CEO, Director, Officer
Corvus Pharmaceuticals, Inc.
(CRVS)
1,490,119
+4%
60,000
$0.75
$44,827.00
BUY
13 Dec 2022
LEA LEIV
Chief Financial Officer, Officer
Corvus Pharmaceuticals, Inc.
(CRVS)
133,238
+34%
34,000
$0.75
$25,639.00
BUY
28 Sep 2022
MILLER RICHARD A MD
President and CEO, Director, Officer
Corvus Pharmaceuticals, Inc.
(CRVS)
1,394,405
+1%
25,000
$0.76
$19,070.00
BUY
20 Sep 2022
MILLER RICHARD A MD
President and CEO, Director, Officer
Corvus Pharmaceuticals, Inc.
(CRVS)
1,361,705
+1%
20,000
$0.81
$16,253.23
BUY
24 Jun 2022
MILLER RICHARD A MD
President and CEO, Director, Officer
Corvus Pharmaceuticals, Inc.
(CRVS)
1,349,405
+0%
10,000
$1.01
$10,134.50
BUY
2 Jun 2022
MILLER RICHARD A MD
President and CEO, Director, Officer
Corvus Pharmaceuticals, Inc.
(CRVS)
1,339,405
+0%
5,890
$0.98
$5,797.20
BUY
31 Mar 2022
MILLER RICHARD A MD
President and CEO, Director, Officer
Corvus Pharmaceuticals, Inc.
(CRVS)
1,333,515
+1%
15,000
$1.64
$24,534.00
BUY
16 Mar 2022
LEA LEIV
Chief Financial Officer, Officer
Corvus Pharmaceuticals, Inc.
(CRVS)
99,238
+97%
49,038
$1.57
$77,045.09
BUY
15 Mar 2022
MILLER RICHARD A MD
President and CEO, Director, Officer
Corvus Pharmaceuticals, Inc.
(CRVS)
1,318,515
+2%
30,000
$1.49
$44,600.00
SELL
30 Sep 2021
EcoR1 Capital, LLC
10% Owner
Corvus Pharmaceuticals, Inc.
(CRVS)
81,077
-98%
5,000,000
$5.01
$25,059,900.00
SELL
20 Sep 2021
ORBIMED ADVISORS LLC
Director, 10% Owner
Corvus Pharmaceuticals, Inc.
(CRVS)
6,943,654
-13%
1,109,644
$6.09
$6,757,732.00
SELL
20 Sep 2021
Thompson Peter A.
Director, 10% Owner
Corvus Pharmaceuticals, Inc.
(CRVS)
6,943,654
-13%
1,109,644
$6.09
$6,757,732.00
BUY
20 Aug 2021
MILLER RICHARD A MD
President and CEO, Director, Officer
Corvus Pharmaceuticals, Inc.
(CRVS)
1,288,515
+0%
10,000
$1.93
$19,254.00
BUY
4 May 2021
MILLER RICHARD A MD
President and CEO, Director, Officer
Corvus Pharmaceuticals, Inc.
(CRVS)
35,714
+100%
35,714
$2.80
$99,999.20
BUY
17 Feb 2021
ORBIMED ADVISORS LLC
Director, 10% Owner
Corvus Pharmaceuticals, Inc.
(CRVS)
8,053,298
+18%
1,285,714
$3.50
$4,499,999.00
BUY
17 Feb 2021
Thompson Peter A.
Director, 10% Owner
Corvus Pharmaceuticals, Inc.
(CRVS)
8,053,298
+18%
1,285,714
$3.50
$4,499,999.00
BUY
17 Feb 2021
MILLER RICHARD A MD
President and CEO, Director, Officer
Corvus Pharmaceuticals, Inc.
(CRVS)
1,278,515
+8%
100,000
$3.50
$350,000.00
SELL
7 Jul 2020
Novo Holdings A/S
10% Owner
Corvus Pharmaceuticals, Inc.
(CRVS)
1,389,498
-52%
1,538,062
$5.31
$8,168,546.50
BUY
12 Nov 2019
MILLER RICHARD A MD
President and CEO, Director, Officer
Corvus Pharmaceuticals, Inc.
(CRVS)
1,178,515
+1%
15,008
$3.00
$45,029.22
BUY
6 Aug 2019
Thompson Peter A.
Director, 10% Owner
Corvus Pharmaceuticals, Inc.
(CRVS)
6,767,584
+2%
142,656
$3.51
$500,722.56
BUY
6 Aug 2019
ORBIMED ADVISORS LLC
Director, 10% Owner
Corvus Pharmaceuticals, Inc.
(CRVS)
6,767,584
+2%
142,656
$3.51
$500,722.56
BUY
6 Aug 2019
MILLER RICHARD A MD
President and CEO, Director, Officer
Corvus Pharmaceuticals, Inc.
(CRVS)
1,163,507
+0%
7,500
$3.56
$26,725.00
SELL
23 Jul 2019
Novo Holdings A/S
10% Owner
Corvus Pharmaceuticals, Inc.
(CRVS)
2,927,560
-33%
1,492,956
$4.07
$6,077,845.50
BUY
27 Jun 2019
Thompson Peter A.
Director, 10% Owner
Corvus Pharmaceuticals, Inc.
(CRVS)
6,624,928
+11%
657,344
$3.72
$2,444,065.20
BUY
27 Jun 2019
ORBIMED ADVISORS LLC
Director, 10% Owner
Corvus Pharmaceuticals, Inc.
(CRVS)
6,624,928
+11%
657,344
$3.72
$2,444,065.20
BUY
13 Jun 2019
MILLER RICHARD A MD
President and CEO, Director, Officer
Corvus Pharmaceuticals, Inc.
(CRVS)
1,156,007
+1%
12,000
$3.41
$40,873.80
BUY
7 Jun 2019
MILLER RICHARD A MD
President and CEO, Director, Officer
Corvus Pharmaceuticals, Inc.
(CRVS)
1,144,007
+1%
15,212
$3.49
$53,038.65
BUY
6 Jun 2019
LEA LEIV
Chief Financial Officer, Officer
Corvus Pharmaceuticals, Inc.
(CRVS)
50,200
+103%
25,500
$3.49
$88,980.00
BUY
27 Dec 2018
MILLER RICHARD A MD
President and CEO, Director, Officer
Corvus Pharmaceuticals, Inc.
(CRVS)
1,128,795
+1%
20,000
$3.29
$65,884.00
BUY
21 Dec 2018
LEA LEIV
Chief Financial Officer, Officer
Corvus Pharmaceuticals, Inc.
(CRVS)
24,700
+100%
24,700
$4.15
$102,408.67
BUY
20 Dec 2018
MILLER RICHARD A MD
President and CEO, Director, Officer
Corvus Pharmaceuticals, Inc.
(CRVS)
1,103,795
+0%
10,000
$4.40
$43,950.00
BUY
6 Dec 2018
MILLER RICHARD A MD
President and CEO, Director, Officer
Corvus Pharmaceuticals, Inc.
(CRVS)
1,118,795
+0%
5,000
$5.99
$29,934.00
BUY
4 Dec 2018
MILLER RICHARD A MD
President and CEO, Director, Officer
Corvus Pharmaceuticals, Inc.
(CRVS)
1,113,795
+0%
1,502
$5.95
$8,936.90
BUY
12 Mar 2018
ADAMS STREET PARTNERS LLC
10% Owner
Corvus Pharmaceuticals, Inc.
(CRVS)
69,864
+113%
588,235
$8.50
$4,999,997.50
BUY
12 Mar 2018
Thompson Peter A.
Director, 10% Owner
Corvus Pharmaceuticals, Inc.
(CRVS)
5,967,584
+10%
588,235
$8.50
$4,999,997.50
BUY
12 Mar 2018
ORBIMED ADVISORS LLC
Director, 10% Owner
Corvus Pharmaceuticals, Inc.
(CRVS)
5,967,584
+10%
588,235
$8.50
$4,999,997.50
BUY
12 Mar 2018
Novo Holdings A/S
10% Owner
Corvus Pharmaceuticals, Inc.
(CRVS)
4,420,516
+36%
1,176,470
$8.50
$9,999,995.00
BUY
12 Mar 2018
Gould Terry P
Director, 10% Owner
Corvus Pharmaceuticals, Inc.
(CRVS)
69,864
+113%
588,235
$8.50
$4,999,997.50
BUY
12 Mar 2018
MILLER RICHARD A MD
President and CEO, Director, Officer
Corvus Pharmaceuticals, Inc.
(CRVS)
1,112,293
+9%
100,000
$8.50
$850,000.00
BUY
20 Nov 2017
MILLER RICHARD A MD
President and CEO, Director, Officer
Corvus Pharmaceuticals, Inc.
(CRVS)
1,012,293
+0%
10,000
$10.79
$107,850.00
BUY
23 Jun 2017
Novo Holdings A/S
10% Owner
Corvus Pharmaceuticals, Inc.
(CRVS)
3,244,046
+0%
20,000
$10.95
$219,000.00
BUY
9 Jun 2017
MILLER RICHARD A MD
President and CEO, Director, Officer
Corvus Pharmaceuticals, Inc.
(CRVS)
999,793
+2%
25,000
$9.88
$247,083.62
BUY
23 Jun 2016
Thompson Peter A.
Director, 10% Owner
Corvus Pharmaceuticals, Inc.
(CRVS)
5,379,349
+0%
1,000
$12.98
$12,983.00
BUY
23 Jun 2016
ORBIMED ADVISORS LLC
Director, 10% Owner
Corvus Pharmaceuticals, Inc.
(CRVS)
5,379,349
+0%
1,000
$12.98
$12,983.00
BUY
17 Jun 2016
Thompson Peter A.
Director, 10% Owner
Corvus Pharmaceuticals, Inc.
(CRVS)
5,378,349
+0%
38,383
$12.75
$489,192.22
BUY
17 Jun 2016
ORBIMED ADVISORS LLC
Director, 10% Owner
Corvus Pharmaceuticals, Inc.
(CRVS)
5,378,349
+0%
38,383
$12.75
$489,192.22
BUY
14 Jun 2016
Thompson Peter A.
Director, 10% Owner
Corvus Pharmaceuticals, Inc.
(CRVS)
5,339,966
+0%
20,000
$12.35
$247,000.00
BUY
14 Jun 2016
ORBIMED ADVISORS LLC
Director, 10% Owner
Corvus Pharmaceuticals, Inc.
(CRVS)
5,339,966
+0%
20,000
$12.35
$247,000.00
BUY
9 Jun 2016
Thompson Peter A.
Director, 10% Owner
Corvus Pharmaceuticals, Inc.
(CRVS)
5,319,966
+0%
50,000
$12.96
$648,100.00
BUY
9 Jun 2016
ORBIMED ADVISORS LLC
Director, 10% Owner
Corvus Pharmaceuticals, Inc.
(CRVS)
5,319,966
+0%
50,000
$12.96
$648,100.00
BUY
20 May 2016
Thompson Peter A.
Director, 10% Owner
Corvus Pharmaceuticals, Inc.
(CRVS)
5,269,966
+0%
4,716
$13.09
$61,732.44
BUY
20 May 2016
ORBIMED ADVISORS LLC
Director, 10% Owner
Corvus Pharmaceuticals, Inc.
(CRVS)
5,269,966
+0%
4,716
$13.09
$61,732.44
BUY
18 May 2016
ORBIMED ADVISORS LLC
Director
Corvus Pharmaceuticals, Inc.
(CRVS)
5,265,189
+0%
6,800
$11.77
$80,035.04
BUY
18 May 2016
Thompson Peter A.
Director, 10% Owner
Corvus Pharmaceuticals, Inc.
(CRVS)
5,265,189
+0%
6,800
$11.77
$80,035.04
BUY
12 May 2016
MILLER RICHARD A MD
President and CEO, Director, Officer
Corvus Pharmaceuticals, Inc.
(CRVS)
1,077,293
+2%
30,300
$10.00
$302,981.00
BUY
12 May 2016
Novo A/S
10% Owner
Corvus Pharmaceuticals, Inc.
(CRVS)
3,224,046
+2%
70,000
$10.00
$700,000.00
BUY
29 Mar 2016
ADAMS STREET PARTNERS LLC
10% Owner
Corvus Pharmaceuticals, Inc.
(CRVS)
694,854
+40%
200,000
$15.00
$3,000,000.00
BUY
29 Mar 2016
Novo A/S
10% Owner
Corvus Pharmaceuticals, Inc.
(CRVS)
3,154,046
+26%
666,666
$15.00
$9,999,990.00
BUY
29 Mar 2016
ORBIMED ADVISORS LLC
Director, 10% Owner
Corvus Pharmaceuticals, Inc.
(CRVS)
5,258,450
+11%
550,000
$15.00
$8,250,000.00
BUY
29 Mar 2016
Thompson Peter A.
Director, 10% Owner
Corvus Pharmaceuticals, Inc.
(CRVS)
5,258,450
+11%
550,000
$15.00
$8,250,000.00
BUY
29 Mar 2016
Gould Terry P
Director, 10% Owner
Corvus Pharmaceuticals, Inc.
(CRVS)
694,854
+40%
200,000
$15.00
$3,000,000.00
Home